Quality of cardiovascular disease care in Ontario, Canada: missed opportunities for prevention - a cross sectional study

BMC Cardiovascular Disorders

George Wells⁷  Ayub Akbari²  Monica Taljaard⁷  Grant Russell³  Catherine Deri-Armstrong¹  Simone Dahrouge⁶  William Hogg⁵  Jatinderpreet Singh⁶  Clare Liddy⁴ 

[1] Department of Economics, University of Ottawa, Ottawa, ON, Canada;Department of Medicine, Division of Nephrology, University of Ottawa, Ottawa, ON, Canada;School of Primary Health Care, Monash University, Victoria, Australia;Department of Family Medicine, University of Ottawa, Ottawa, ON, Canada;Institute of Population Health, University of Ottawa, Ottawa, ON, Canada;C.T. Lamont Primary Health Care Research Centre, Bruyère Research Institute, Ottawa, ON, Canada;Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, ON, Canada

关键词: Quality of care;    Preventive care;    Evidence-based care;    Diabetes;    Primary care;    Cardiovascular disease;   

Others  :  1084412
DOI  :  10.1186/1471-2261-12-74

 received in 2012-06-21, accepted in 2012-09-06,  发布年份 2012

【 摘 要 】

Background

Primary care plays a key role in the prevention and management of cardiovascular disease (CVD). We examined primary care practice adherence to recommended care guidelines associated with the prevention and management of CVD for high risk patients.

Methods

We conducted a secondary analysis of cross-sectional baseline data collected from 84 primary care practices participating in a large quality improvement initiative in Eastern Ontario from 2008 to 2010. We collected medical chart data from 4,931 patients who either had, or were at high risk of developing CVD to study adherence rates to recommended guidelines for CVD care and to examine the proportion of patients at target for clinical markers such as blood pressure, lipid levels and hemoglobin A1c.

Results

Adherence to preventive care recommendations was poor. Less than 10% of high risk patients received a waistline measurement, half of the smokers received cessation advice, and 7.7% were referred to a smoking cessation program. Gaps in care exist for diabetes and kidney disease as 54.9% of patients with diabetes received recommended hemoglobin-A1c screenings, and only 55.8% received an albumin excretion test. Adherence rates to recommended guidelines for coronary artery disease, hypertension, and dyslipidemia were high (>75%); however <50% of patients were at target for blood pressure or LDL-cholesterol levels (37.1% and 49.7% respectively), and only 59.3% of patients with diabetes were at target for hemoglobin-A1c.

Conclusions

There remain significant opportunities for primary care providers to engage high risk patients in prevention activities such as weight management and smoking cessation. Despite high adherence rates for hypertension, dyslipidemia, and coronary artery disease, a significant proportion of patients failed to meet treatment targets, highlighting the complexity of caring for people with multiple chronic conditions.

Trial Registration

NCT00574808

【 授权许可】

   
2012 Liddy et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Campbell NR, Onysko J, Johansen H, Gao RN: Changes in cardiovascular deaths and hospitalization in Canada. Can J Cardiol 2006, 22:425-427.
• [2]Johansen H, Thillaiampalam S, Nguyen D, Sambell C: Diseases of the circulatory system–hospitalization and mortality. Health Rep 2005, 17:49-53.
• [3]Blackadar R, Houle M: The Alberta Cardiac Access Collaborative: improving the cardiac patient journey. Healthc Q 2009, 13:Spec No:85-Spec No:90.
• [4]Boyd DR, Genuis SJ: The environmental burden of disease in Canada: respiratory disease, cardiovascular disease, cancer, and congenital affliction. Environ Res 2008, 106:240-249.
• [5]Manuel DG, Leung M, Nguyen K, Tanuseputro P, Johansen H: Burden of cardiovascular disease in Canada. Can J Cardiol 2003, 19:997-1004.
• [6]Heart and Stroke Foundation of Canada: The Growing Burden of Heart Disease and Stroke in Canada. Heart and Stroke Foundation, Canada; 2003.
• [7]Glazier RH, Moineddin R, Agha MM: The Impact of not having a primary care physician among people with chronic conditions. ICES Investigative Report. Institute for Clinical Evaluative Sciences, Toronto; 2008.
• [8]Chan BT: The declining comprehensiveness of primary care. CMAJ 2002, 166:429-434.
• [9]Cifuentes M, Fernald DH, Green LA, Niebauer LJ, Crabtree BF, Stange KC, Hassmiller SB: Prescription for health: changing primary care practice to foster healthy behaviors. Ann Fam Med 2005, 3(Suppl 2):S4-S11.
• [10]Liddy C, Hogg W, Russell G, Wells G, Armstrong CD, Akbari A, Dahrouge S, Taljaard M, Mayo-Bruinsma L, Singh J, et al.: Improved delivery of cardiovascular care (IDOCC) through outreach facilitation: study protocol and implementation details of a cluster randomized controlled trial in primary care. Implement Sci 2011, 6:110. BioMed Central Full Text
• [11]Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A: Improving chronic illness care: translating evidence into action. Health Aff (Millwood) 2001, 20:64-78.
• [12]Bains N: Population Health Profile: Champlain LHIN. Champlain LHIN 2008, 1-4.
• [13]Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.
• [14]Hogg W, Gyorfi-Dyke E, Johnston S, Dahrouge S, Liddy C, Russell G, Kristjansson E: Conducting chart audits in practice-based primary care research: a user's guide. Can Fam Physician 2010, 56:495-496.
• [15]Liddy C, Wiens M, Hogg W: Methods to achieve high interrater reliability in data collection from primary care medical records. Ann Fam Med 2011, 9:57-62.
• [16]Montoya L, Liddy C, Hogg W, Papadakis S, Dojeiji L, Russell G, Akbari A, Pipe A, Higginson L: Development of the Champlain primary care cardiovascular disease prevention and management guideline: tailoring evidence to community practice. Can Fam Physician 2011, 57:e202-e207.
• [17]AGREE Collaboration: Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE Project. Qual Saf Health Care 2003, 12:18-23.
• [18]Donner A, Klar N: Design and Analysis of Cluster Randomization Trials in Health Research. Wiley, New York; 2000.
• [19]SAS Institute Inc: SAS 9.2. Cary, NC, USA; 2008.
• [20]Bullen C: Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease. Expert Rev Cardiovasc Ther 2008, 6:883-895.
• [21]Critchley JA, Capewell S: Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 2003, 290(1):86-97.
• [22]Ford ES, Bergmann MM, Kroger J, Schienkiewitz A, Weikert C, Boeing H: Healthy living is the best revenge: findings from the European Prospective Investigation Into Cancer and Nutrition-Potsdam study. Arch Intern Med 2009, 169:1355-1362.
• [23]Center for Disease Control and Prevention: Smoking-cessation advice from health-care providers- Canada 2005. MMWR Morb Mortal Wkly Rep 2007, 56:1145-1154.
• [24]Holtrop JS, Malouin R, Weismantel D, Wadland WC: Clinician perceptions of factors influencing referrals to a smoking cessation program. BMC Fam Pract 2008, 9:18. BioMed Central Full Text
• [25]Schnoll RA, Rukstalis M, Wileyto EP, Shields AE: Smoking cessation treatment by primary care physicians: An update and call for training. Am J Prev Med 2006, 31:233-239.
• [26]Puska PM, Barrueco M, Roussos C, Hider A, Hogue S: The participation of health professionals in a smoking-cessation programme positively influences the smoking cessation advice given to patients. Int J Clin Pract 2005, 59:447-452.
• [27]Stead M, Angus K, Holme I, Cohen D, Tait G: Factors influencing European GPs' engagement in smoking cessation: a multi-country literature review. Br J Gen Pract 2009, 59:682-690.
• [28]Hollis JF, McAfee TA, Fellows JL, Zbikowski SM, Stark M, Riedlinger K: The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline. Tob Control 2007, 16(Suppl 1):i53-i59.
• [29]Lai DT, Cahill K, Qin Y, Tang JL: Motivational interviewing for smoking cessation. Cochrane Database Syst Rev 2010, CD006936:1-37.
• [30]Almdal T, Scharling H, Jensen JS, Vestergaard H: The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 2004, 164:1422-1426.
• [31]Callahan A, Amarenco P, Goldstein LB, Sillesen H, Messig M, Samsa GP, Altafullah I, Ledbetter LY, MacLeod MJ, Scott R, et al.: Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Arch Neurol 2011, 68:1245-1251.
• [32]Haffner SM: Coronary heart disease in patients with diabetes. N Engl J Med 2000, 342:1040-1042.
• [33]Saydah SH, Eberhardt MS, Loria CM, Brancati FL: Age and the burden of death attributable to diabetes in the United States. Am J Epidemiol 2002, 156:714-719.
• [34]Agha A, Dillon D, Corbett M, Sreenan S: Target blood pressure for patients with type 2 diabetes is difficult to achieve in the setting of a busy diabetes clinic. Ir J Med Sci 2003, 172:168-170.
• [35]Kennedy AG, MacLean CD, Littenberg B, Ades PA, Pinckney RG: The challenge of achieving national cholesterol goals in patients with diabetes. Diabetes Care 2005, 28:1029-1034.
• [36]Saydah SH, Fradkin J, Cowie CC: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004, 291:335-342.
• [37]Program CHE: 2011 Canadian Hypertension Education Program recommendations: An annual update. Can Fam Physician 2011, 57:1393-1397.
• [38]Leenen FH, Dumais J, McInnis NH, Turton P, Stratychuk L, Nemeth K, Lum-Kwong MM, Fodor G: Results of the Ontario survey on the prevalence and control of hypertension. CMAJ 2008, 178:1441-1449.
• [39]McAlister FA, Wilkins K, Joffres M, Leenen FH, Fodor G, Gee M, Tremblay MS, Walker R, Johansen H, Campbell N: Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 2011, 183:1007-1013.
• [40]Egan BM, Zhao Y, Axon RN: US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA 2010, 303:2043-2050.
• [41]Pereira M, Lunet N, Azevedo A, Barros H: Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens 2009, 27:963-975.
• [42]Bolli P, Campbell NR: Do recommendations for the management of hypertension improve cardiovascular outcome? The canadian experience. Int J Hypertens 2011, 2011:410754.
• [43]Akbari A, Swedko PJ, Clark HD, Hogg W, Lemelin J, Magner P, Moore L, Ooi D: Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program. Arch Intern Med 2004, 164:1788-1792.
• [44]Allen AS, Forman JP, Orav EJ, Bates DW, Denker BM, Sequist TD: Primary care management of chronic kidney disease. J Gen Intern Med 2011, 26:386-392.
• [45]Jain A, Hemmelgarn BR: Impact of estimated glomerular filtration rate reporting on nephrology referrals: a review of the literature. Curr Opin Nephrol Hypertens 2011, 20:218-223.
• [46]National Institutes of Health: Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. NIH Publications, Bethesda; 1998.
• [47]Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB: Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 2008, 117:1658-1667.
• [48]Douketis JD, Paradis G, Keller H, Martineau C: Canadian guidelines for body weight classification in adults: application in clinical practice to screen for overweight and obesity and to assess disease risk. CMAJ 2005, 172:995-998.
• [49]Brown P: Waist circumference in primary care. Prim Care Diabetes 2009, 3:259-261.
• [50]Dunkley AJ, Stone MA, Patel N, Davies MJ, Khunti K: Waist circumference measurement: knowledge, attitudes and barriers in patients and practitioners in a multi-ethnic population. Fam Pract 2009, 26:365-371.
• [51]McPherson R, Frohlich J, Fodor G, Genest J: Canadian Cardiovascular Society: Canadian Cardiovascular Society position statement–recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol 2006, 22:913-927.
• [52]McKenney JM: Optimizing LDL-C lowering with statins. Am J Ther 2004, 11:54-59.
• [53]Senecal M, Fodor G, Gagne C, Genest J, Lavoie MA, McPherson R, Marentette M, Sebaldt RJ: Limitations of statin monotherapy for the treatment of dyslipidemia: a projection based on the Canadian lipid study–observational. Curr Med Res Opin 2009, 25:47-55.
• [54]Fortin M, Contant E, Savard C, Hudon C, Poitras ME, Almirall J: Canadian guidelines for clinical practice: an analysis of their quality and relevance to the care of adults with comorbidity. BMC Fam Pract 2011, 12:74. BioMed Central Full Text
• [55]Starfield B: Threads and yarns: weaving the tapestry of comorbidity. Ann Fam Med 2006, 4:101-103.
• [56]Van WC, Schellevis FG: Comorbidity and guidelines: conflicting interests. Lancet 2006, 367:550-551.
• [57]Liddy C, Singh J, Hogg W, Dahrouge S, Taljaard M: Comparison of primary care models in the prevention of cardiovascular disease - a cross sectional study. BMC Fam Pract 2011, 12:114. BioMed Central Full Text